Drug Insights

Effortless Searching: How to Find Benzoyl peroxide on Synapse

21 March 2024
2 min read

Benzoyl peroxide, a small molecule drug with potent antibacterial properties, was originally sanctioned in January 1968 by Maruho Pharmaceutical for treating acne. By penetrating deep into the skin's pores, this wonder drug unclogs them, successfully reducing inflammation and thwarting new pimples from forming. It's available in various forms, including creams, gels, and washes, and is typically applied topically to the impacted regions of the skin. Although generally well-tolerated, benzoyl peroxide may cause a few side effects, including skin dryness, redness, and peeling. Despite its shortcomings, benzoyl peroxide remains an effective and widely used remedy for acne. Click on the image below to begin the exploration journey of Benzoyl peroxide through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

AstraZeneca Eyes Amolyt Pharma Acquisition to Expand Rare Disease Portfolio
Latest Hotspot
3 min read
AstraZeneca Eyes Amolyt Pharma Acquisition to Expand Rare Disease Portfolio
20 March 2024
AstraZeneca plans to purchase Amolyt Pharma, thereby broadening its advanced portfolio in uncommon disorders.
Read →
GPCR Targets and Pipeline at the JP Morgan Healthcare Conference 2024 (1)
GPCR Targets and Pipeline at the JP Morgan Healthcare Conference 2024 (1)
20 March 2024
This article will introduce the GPCR targets and pipelines that received attention at the JP Morgan Healthcare Conference 2024.
Read →
Lirum BioMed's LX-101 Shows Promise Against IGF-Linked Tumors,Set for 2024 ESMO Spotlight
Latest Hotspot
3 min read
Lirum BioMed's LX-101 Shows Promise Against IGF-Linked Tumors,Set for 2024 ESMO Spotlight
20 March 2024
Lirum BioMed Reveals Encouraging Results for Its Innovative Treatment LX-101, Showing Strong Early-Phase Effectiveness in Tackling IGF-Linked Tumors, Scheduled for Discussion at the 2024 ESMO Congress on Sarcoma and Uncommon Cancers.
Read →
Making the Most Out of Synapse: Searching for Levetiracetam
Drug Insights
2 min read
Making the Most Out of Synapse: Searching for Levetiracetam
20 March 2024
Levetiracetam, a diminutive molecular entity, has been engineered to hone in on the synaptic vesicle protein 2A (SV2A) as a modulation target.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.